Cargando…

Red Cell Distribution Width and Mortality in Patients With Acute Coronary Syndrome: A Meta-Analysis on Prognosis

BACKGROUND: Red cell distribution width (RDW), a routine component of the complete blood count (CBC), measures variation in the size of circulating erythrocytes. It has been associated with several clinical outcomes in cardiovascular disease. We sought to strengthen the association between RDW and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Abrahan, Lauro L., Ramos, John Daniel A., Cunanan, Elleen L., Tiongson, Marc Denver A., Punzalan, Felix Eduardo R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997444/
https://www.ncbi.nlm.nih.gov/pubmed/29904449
http://dx.doi.org/10.14740/cr732w
_version_ 1783331050443767808
author Abrahan, Lauro L.
Ramos, John Daniel A.
Cunanan, Elleen L.
Tiongson, Marc Denver A.
Punzalan, Felix Eduardo R.
author_facet Abrahan, Lauro L.
Ramos, John Daniel A.
Cunanan, Elleen L.
Tiongson, Marc Denver A.
Punzalan, Felix Eduardo R.
author_sort Abrahan, Lauro L.
collection PubMed
description BACKGROUND: Red cell distribution width (RDW), a routine component of the complete blood count (CBC), measures variation in the size of circulating erythrocytes. It has been associated with several clinical outcomes in cardiovascular disease. We sought to strengthen the association between RDW and mortality in patients admitted for acute coronary syndrome (ACS) by pooling together data from available studies. METHODS: Studies that fulfilled the following were identified for analysis: 1) observational; 2) included patients admitted for ACS; 3) reported data on all-cause or cardiovascular (CV) mortality in association with a low or high RDW; and 4) used logistic regression analysis to control for confounders. Using MEDLINE, Clinical Key, ScienceDirect, Scopus, and Cochrane Central Register of Controlled Trials databases, a search for eligible studies was conducted until January 9, 2017. The quality of each study was evaluated using the Newcastle-Ottawa Quality Assessment Scale. Our primary outcome of interest was all-cause or CV mortality. We also investigated the impact of RDW on major adverse cardiovascular events (MACEs) for the studies that reported these outcomes. Review Manager (RevMan) 5.3 was utilized to perform Mantel-Haenzel analysis of random effects and compute for relative risk. RESULTS: We identified 13 trials involving 10,410 patients, showing that in ACS, a low RDW is associated with a statistically significant lower all-cause or CV mortality (RR 0.35, (95% CI 0.30 to 0.40), P < 0.00001, I(2) = 53%), a finding that was consistent both in the short- and long-term. CONCLUSIONS: A low RDW is also associated with lower risk for MACEs after an ACS (RR 0.56, (95% CI 0.51 to 0.61), P < 0.00001, I(2) = 91%). A low RDW during an ACS is associated with lower all-cause or CV mortality and lower risk of subsequent MACEs, providing us with a convenient and inexpensive risk stratification tool in ACS patients.
format Online
Article
Text
id pubmed-5997444
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-59974442018-06-14 Red Cell Distribution Width and Mortality in Patients With Acute Coronary Syndrome: A Meta-Analysis on Prognosis Abrahan, Lauro L. Ramos, John Daniel A. Cunanan, Elleen L. Tiongson, Marc Denver A. Punzalan, Felix Eduardo R. Cardiol Res Original Article BACKGROUND: Red cell distribution width (RDW), a routine component of the complete blood count (CBC), measures variation in the size of circulating erythrocytes. It has been associated with several clinical outcomes in cardiovascular disease. We sought to strengthen the association between RDW and mortality in patients admitted for acute coronary syndrome (ACS) by pooling together data from available studies. METHODS: Studies that fulfilled the following were identified for analysis: 1) observational; 2) included patients admitted for ACS; 3) reported data on all-cause or cardiovascular (CV) mortality in association with a low or high RDW; and 4) used logistic regression analysis to control for confounders. Using MEDLINE, Clinical Key, ScienceDirect, Scopus, and Cochrane Central Register of Controlled Trials databases, a search for eligible studies was conducted until January 9, 2017. The quality of each study was evaluated using the Newcastle-Ottawa Quality Assessment Scale. Our primary outcome of interest was all-cause or CV mortality. We also investigated the impact of RDW on major adverse cardiovascular events (MACEs) for the studies that reported these outcomes. Review Manager (RevMan) 5.3 was utilized to perform Mantel-Haenzel analysis of random effects and compute for relative risk. RESULTS: We identified 13 trials involving 10,410 patients, showing that in ACS, a low RDW is associated with a statistically significant lower all-cause or CV mortality (RR 0.35, (95% CI 0.30 to 0.40), P < 0.00001, I(2) = 53%), a finding that was consistent both in the short- and long-term. CONCLUSIONS: A low RDW is also associated with lower risk for MACEs after an ACS (RR 0.56, (95% CI 0.51 to 0.61), P < 0.00001, I(2) = 91%). A low RDW during an ACS is associated with lower all-cause or CV mortality and lower risk of subsequent MACEs, providing us with a convenient and inexpensive risk stratification tool in ACS patients. Elmer Press 2018-06 2018-06-06 /pmc/articles/PMC5997444/ /pubmed/29904449 http://dx.doi.org/10.14740/cr732w Text en Copyright 2018, Abrahan et al. http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Abrahan, Lauro L.
Ramos, John Daniel A.
Cunanan, Elleen L.
Tiongson, Marc Denver A.
Punzalan, Felix Eduardo R.
Red Cell Distribution Width and Mortality in Patients With Acute Coronary Syndrome: A Meta-Analysis on Prognosis
title Red Cell Distribution Width and Mortality in Patients With Acute Coronary Syndrome: A Meta-Analysis on Prognosis
title_full Red Cell Distribution Width and Mortality in Patients With Acute Coronary Syndrome: A Meta-Analysis on Prognosis
title_fullStr Red Cell Distribution Width and Mortality in Patients With Acute Coronary Syndrome: A Meta-Analysis on Prognosis
title_full_unstemmed Red Cell Distribution Width and Mortality in Patients With Acute Coronary Syndrome: A Meta-Analysis on Prognosis
title_short Red Cell Distribution Width and Mortality in Patients With Acute Coronary Syndrome: A Meta-Analysis on Prognosis
title_sort red cell distribution width and mortality in patients with acute coronary syndrome: a meta-analysis on prognosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997444/
https://www.ncbi.nlm.nih.gov/pubmed/29904449
http://dx.doi.org/10.14740/cr732w
work_keys_str_mv AT abrahanlaurol redcelldistributionwidthandmortalityinpatientswithacutecoronarysyndromeametaanalysisonprognosis
AT ramosjohndaniela redcelldistributionwidthandmortalityinpatientswithacutecoronarysyndromeametaanalysisonprognosis
AT cunananelleenl redcelldistributionwidthandmortalityinpatientswithacutecoronarysyndromeametaanalysisonprognosis
AT tiongsonmarcdenvera redcelldistributionwidthandmortalityinpatientswithacutecoronarysyndromeametaanalysisonprognosis
AT punzalanfelixeduardor redcelldistributionwidthandmortalityinpatientswithacutecoronarysyndromeametaanalysisonprognosis